Apretude is approved for use in at-risk adults and adolescents to reduce the risk of sexually acquired HIV.
Best nonhormone methods for managing vasomotor symptoms
The most recommended and non-recommended methods of nonhormone therapy for treatment of vasomotor symptoms were discussed at The Menopause Society 2023 Annual Conference.
The Importance of Including Hemoglobinopathies as a Part of Carrier Screening Panels
PTSD linked to worse sexual functioning in midlife women
A recent study measuring sexual functioning in women with post-traumatic stress disorder was discussed at The Menopause Society 2023 Annual Meeting.
Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 2
This is part 2 of a 2-part series. In this bonus episode of Pap Talk, get an exclusive recap of Kimberly Kho, MD's presentation from AAGL 2022 on alternatives to hysterectomy and uterine-preserving options for fibroids.
Ibrexafungerp tablets receive nationwide recall
A nationwide recall has been issued for ibrexafungerp products after a potential cross contamination with a non-antibacterial ß-lactam drug substance was discovered.
Hot flashes linked to Alzheimer’s disease risk
In a recent study highlighted at the Menopause Society 2023 Annual Meeting, a correlation was found between the number of hot flashes experienced and the risk of Alzheimer’s disease among perimenopausal and postmenopausal women.
2 Clarke Drive Cranbury, NJ 08512